Pleural Disease Market to Reach $6.09 billion by 2030:
Pleural disease encompasses various conditions affecting the pleura, the thin membrane surrounding the lungs. Pleurisy involves inflammation of the pleura,...
Source: globenewswire.com
Page 15 - Molecular Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Molecular Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Molecular Testing Today - Breaking & Trending Today
Natera Receives Medicare Coverage for Prospera Lung Transplant Rejection Test
The test will be covered under the existing LCD for molecular testing for solid organ transplant rejection in surveillance monitoring.
Source: genomeweb.com
Natera's Prospera™ Lung Transplant Assessment Test Granted Medicare Coverage
Represents third covered indication for Prospera ... -Today at 09:07 am- MarketScreener
Source: marketscreener.com
CareDx Comments on Issuance of Proposed LCD for Molecular Testing for Solid Allograft Rejection
CareDx Welcomes Open Process to Gain Transplant Community Feedback on Critical Medicare Coverage Decision ... -August 11, 2023 at 07:01 am- MarketScreener
Source: marketscreener.com
Treatment for Patients Unsuitable for or Refractory to Consolidation Durvalumab
Tina Cascone, MD, Ben Levy, MD, and Sandip Patel, MD, offer insights into the treatment approach in patients with unresectable early-stage NSCLC who are unsuitable for consolidation durvalumab or who progress on consolidation durvalumab.
Source: onclive.com